NCPDP - Changes to Compound Medications

NCPDP, the governing body that provides industry standards for the transmission of electronic
prescriptions, has issued a change to script standards that will go into effect on December 30th, 2019. The latest change to the NCPDP script standard will impact how providers send compound medications.

Now, you will have two options when prescribing compound drugs:

The first option is to choose a "Preferred Name". When you choose to use the Preferred Name for a compound medication, you won't need to list the ingredients but you will need to select the DEA Schedule. If the compound contains a controlled substance, you must select the schedule of the most restrictive controlled substance.

In order to add compound medications using the Preferred Name, you'll need to click on "Medication Management" in the EHR's "Utilities".


By selecting "Preferred Name", you are indicating that all parties (the practice and the pharmacy) know what ingredients are included in the compound medication. Once this is selected, you will see the option for the drug schedule.


The second option is to enter all of the ingredients and other required information (including quantity, quantity unit, etc.) to transmit the prescriptions as structured medications.

In order to add compound medications as structured medications, you will need to click on "Medication Management" in the EHR's "Utilities".


To add ingredients, do not select "Preferred Name". Once you select "Add", you will input all required fields on the screen below.


You can find out more about the NCPDP changes here: 

Still need help? Contact us!

Have a great idea? Tell us about it!

Was this article helpful?
0 out of 0 found this helpful